Award
NIH Reporter #1U01FD009015-01
Clinical and Usability Validation of Gait Velocity (SV95C) Measured from Wearable Digital Sensors
Recipient
Massachusetts General Hospital
Award Amount
$878,203.00
Ceiling
$878,203.00
Awarded
September 23, 2026
Identifier
1U01FD009015-01
The FDA-funded project will assess whether wearable sensor-measured SV95C can serve as a meaningful efficacy endpoint in ALS clinical trials.
Description
A project to validate the clinical trial readiness of Stride Velocity 95th Centile (SV95C), a wearable-derived gait measure, in patients with amyotrophic lateral sclerosis (ALS), including assessment of its validity, responsiveness, clinical meaning, and usability.